Riccardo Ricotta Selected Research

Polyphenols

1/2022

An Olive Oil Mill Wastewater Extract Improves Chemotherapeutic Activity Against Breast Cancer Cells While Protecting From Cardiotoxicity.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Riccardo Ricotta Research Topics

Disease

13	Renal Cell Carcinoma (Grawitz Tumor) 01/2021 - 10/2011
11	Neoplasms (Cancer) 01/2022 - 01/2006
7	Colorectal Neoplasms (Colorectal Cancer) 01/2017 - 03/2004
4	Prostatic Neoplasms (Prostate Cancer) 01/2021 - 11/2004
2	Breast Neoplasms (Breast Cancer) 01/2022 - 04/2005
2	Colonic Neoplasms (Colon Cancer) 10/2021 - 05/2008
2	Neoplasm Metastasis (Metastasis) 01/2019 - 06/2015
1	Cardiotoxicity 01/2022
1	Inflammation (Inflammations) 01/2021
1	Urogenital Neoplasms 01/2021
1	Clear-cell metastatic renal cell carcinoma 06/2015
1	Carcinogenesis 03/2014
1	Disease Progression 09/2007
1	Neutropenia 12/2006
1	Infections 12/2006
1	Neuroendocrine Tumors (Neuroendocrine Tumor) 01/2006
1	Carcinoma (Carcinomatosis) 11/2004

Drug/Important Bio-Agent (IBA)

4	cabozantinibIBA 10/2020 - 01/2018
3	Immune Checkpoint InhibitorsIBA 01/2022 - 01/2020
3	Biomarkers (Surrogate Marker)IBA 01/2021 - 03/2014
3	regorafenibIBA 01/2016 - 05/2013
2	Hemoglobins (Hemoglobin)IBA 12/2019 - 06/2015
2	Everolimus FDA Link 01/2018 - 01/2018
2	Sunitinib (Sutent)FDA Link 01/2018 - 10/2011
2	Pharmaceutical PreparationsIBA 01/2017 - 06/2016
2	Docetaxel (Taxotere)FDA Link 06/2016 - 07/2015
1	Antineoplastic Agents (Antineoplastics)IBA 01/2022
1	thiazolyl blueIBA 01/2022
1	WastewaterIBA 01/2022
1	PolyphenolsIBA 01/2022
1	AnthracyclinesIBA 01/2022
1	Olive OilIBA 01/2022
1	Doxorubicin (Adriamycin)FDA LinkGeneric 01/2022
1	AntimetabolitesIBA 01/2022
1	Tissue Inhibitor of Metalloproteinase-1IBA 10/2021
1	CytokinesIBA 10/2021
1	Conditioned Culture MediaIBA 10/2021
1	Tissue Inhibitor of Metalloproteinase-2IBA 10/2021
1	Metalloproteases (Metalloproteinases)IBA 10/2021
1	CeramidesIBA 01/2021
1	ElementsIBA 01/2021
1	NivolumabIBA 01/2021
1	mesoglycanIBA 01/2020
1	Axitinib (AG 013736)IBA 01/2018
1	abirateroneIBA 06/2016
1	Phosphotransferases (Kinase)IBA 05/2016
1	Vascular Endothelial Growth Factor Receptors (VEGF Receptors)IBA 02/2016
1	enzalutamideIBA 07/2015
1	cabazitaxel FDA Link 07/2015
1	Abiraterone AcetateIBA 07/2015
1	nasIBA 07/2015
1	pazopanib FDA Link 05/2014
1	Growth Factor ReceptorsIBA 03/2014
1	Angiopoietin-1IBA 03/2014
1	Protein Kinases (Protein Kinase)IBA 03/2014
1	Panitumumab (Vectibix)FDA Link 03/2013
1	Cetuximab (Erbitux)FDA Link 03/2013
1	Indicators and Reagents (Reagents)IBA 03/2013
1	ErbB Receptors (EGF Receptor)IBA 03/2013
1	Sorafenib (BAY 43-9006)FDA Link 10/2011
1	Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF)IBA 12/2006
1	Granulocyte Colony-Stimulating Factor (G-CSF)IBA 12/2006
1	pegfilgrastim (Neulasta)FDA Link 12/2006
1	Filgrastim (Neupogen)FDA Link 12/2006
1	Colony-Stimulating Factors (Colony Stimulating Factor)IBA 12/2006
1	Biological ProductsIBA 01/2006
1	Capecitabine (Xeloda)FDA Link 04/2005
1	Hormones (Hormone)IBA 11/2004
1	AndrogensIBA 11/2004
1	raltitrexed (D 1694)IBA 03/2004
1	Oxaliplatin (Eloxatin)FDA LinkGeneric 03/2004

Therapy/Procedure

12	Therapeutics 01/2022 - 11/2004
5	Drug Therapy (Chemotherapy) 01/2022 - 11/2004
2	Castration 06/2016 - 07/2015
1	Immunotherapy 01/2021
1	Precision Medicine 01/2021
1	Treatment Delay 01/2019
1	Aftercare (After-Treatment) 01/2018
1	Palliative Care (Palliative Therapy) 05/2008
1	Injections 12/2006
1	Radiotherapy 11/2004